Evidence map›Paper›PMID 35065714›Full record

ArticleNeuron2022

Presynaptic autophagy is coupled to the synaptic vesicle cycle via ATG-9.

Sisi Yang, Daehun Park, Laura Manning, Sarah E Kargbo-Hill, Mian Cao, Zhao Xuan, Ian Gonzalez, Yongming Dong, Benjamin Clark, Lin Shao and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 100 citations in OpenAlex.

  1. Synaptic Proteostasis in Health and Disease.Journal of neurochemistry · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Roles in physiology and disease of the inositol phosphatase synaptojanin 1.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2026
    Review
  9. White matter injury after brain ischemia.Experimental neurology · 2026
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Sisi YangProgram in Cellular Neuroscience, Neurodegeneration and Repair, Departments of Neuroscience and of Cell Biology, Yale University School of Medicine, 260 Whitney Avenue, YSB C167, New Haven, CT 06511, USA.
Daehun ParkProgram in Cellular Neuroscience, Neurodegeneration and Repair, Departments of Neuroscience and of Cell Biology, Yale University School of Medicine, 260 Whitney Avenue, YSB C167, New Haven, CT 06511, USA; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06510, USA; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA.
Laura ManningProgram in Cellular Neuroscience, Neurodegeneration and Repair, Departments of Neuroscience and of Cell Biology, Yale University School of Medicine, 260 Whitney Avenue, YSB C167, New Haven, CT 06511, USA.
Sarah E Kargbo-HillProgram in Cellular Neuroscience, Neurodegeneration and Repair, Departments of Neuroscience and of Cell Biology, Yale University School of Medicine, 260 Whitney Avenue, YSB C167, New Haven, CT 06511, USA.
Mian CaoProgram in Cellular Neuroscience, Neurodegeneration and Repair, Departments of Neuroscience and of Cell Biology, Yale University School of Medicine, 260 Whitney Avenue, YSB C167, New Haven, CT 06511, USA; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06510, USA; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA.
Zhao XuanProgram in Cellular Neuroscience, Neurodegeneration and Repair, Departments of Neuroscience and of Cell Biology, Yale University School of Medicine, 260 Whitney Avenue, YSB C167, New Haven, CT 06511, USA.
Ian GonzalezProgram in Cellular Neuroscience, Neurodegeneration and Repair, Departments of Neuroscience and of Cell Biology, Yale University School of Medicine, 260 Whitney Avenue, YSB C167, New Haven, CT 06511, USA.
Yongming DongDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Benjamin ClarkProgram in Cellular Neuroscience, Neurodegeneration and Repair, Departments of Neuroscience and of Cell Biology, Yale University School of Medicine, 260 Whitney Avenue, YSB C167, New Haven, CT 06511, USA.
Lin ShaoProgram in Cellular Neuroscience, Neurodegeneration and Repair, Departments of Neuroscience and of Cell Biology, Yale University School of Medicine, 260 Whitney Avenue, YSB C167, New Haven, CT 06511, USA.
Ifechukwu OkekeProgram in Cellular Neuroscience, Neurodegeneration and Repair, Departments of Neuroscience and of Cell Biology, Yale University School of Medicine, 260 Whitney Avenue, YSB C167, New Haven, CT 06511, USA.
Agustin Almoril-PorrasProgram in Cellular Neuroscience, Neurodegeneration and Repair, Departments of Neuroscience and of Cell Biology, Yale University School of Medicine, 260 Whitney Avenue, YSB C167, New Haven, CT 06511, USA.
Jihong BaiDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Pietro De CamilliProgram in Cellular Neuroscience, Neurodegeneration and Repair, Departments of Neuroscience and of Cell Biology, Yale University School of Medicine, 260 Whitney Avenue, YSB C167, New Haven, CT 06511, USA; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06510, USA; Kavli Institute for Neuroscience, Yale University School of Medicine, New Haven, CT 06510, USA; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA.
Daniel A Colón-RamosProgram in Cellular Neuroscience, Neurodegeneration and Repair, Departments of Neuroscience and of Cell Biology, Yale University School of Medicine, 260 Whitney Avenue, YSB C167, New Haven, CT 06511, USA; Instituto de Neurobiología José del Castillo, Recinto de Ciencias Médicas, Universidad de Puerto Rico, 201 Boulevard del Valle, San Juan, PR 00901, USA; Wu Tsai Institute, Yale University, New Haven, CT 06510, USA. Electronic address: daniel.colon-ramos@yale.edu.
Yale University · USHoward Hughes Medical Institute · USFred Hutch Cancer Center · USUniversity of Puerto Rico System · PR

Funding

Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI GERALD I SHULMAN · 1993 to 2026
$44.0M
Yale/NIDA Neuroproteomics Research CenterP30DA018343 · NIDA · YALE UNIVERSITY · PI ANGUS C. NAIRN, Kenneth Robert WILLIAMS · 2004 to 2026
$37.1M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
Powering the Brain: the Cell Biology of NeuroenergeticsDP1NS111778 · NINDS · YALE UNIVERSITY · PI COLON-RAMOS, DANIEL A · 2018 to 2022
$5.9M
MOLECULAR MECHANISMS IN SYNAPTIC VESICLE RECYCLINGR01NS036251 · NINDS · YALE UNIVERSITY · PI DE CAMILLI, PIETRO · 1997 to 2021
$4.7M
Molecular Interplay of Endocytic ProteinsR01NS115974 · NINDS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Jihong Bai · 2020 to 2026
$4.2M
Cellular and molecular mechanisms that temporally and spatially restrict synapticR01NS076558 · NINDS · YALE UNIVERSITY · PI COLON-RAMOS, DANIEL A · 2012 to 2022
$4.1M
Molecular Mechanisms in Synaptic Vesicle RecyclingR37NS036251 · NINDS · YALE UNIVERSITY · PI DE CAMILLI, PIETRO · 2010 to 2016
$2.7M
Signaling Pathways that Modulate Neuronal ActivityR01NS109476 · NINDS · UNIVERSITY OF WASHINGTON · PI Michael Ailion, Jihong Bai · 2020 to 2026
$2.5M
Molecular Mechanisms That Control the Quality of Synaptic Vesicle RecyclingR01GM127857 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BAI, JIHONG · 2018 to 2021
$2.0M
NIDA NIH HHS P30 DA018343NIDDK NIH HHS P30 DK045735NIGMS NIH HHS R01 GM127857NIH HHS P40 OD010440NINDS NIH HHS DP1 NS111778NINDS NIH HHS R01 NS036251NINDS NIH HHS R01 NS076558NINDS NIH HHS R01 NS109476NINDS NIH HHS R01 NS115974NINDS NIH HHS R37 NS036251
6 · The paper itself

Abstract

Autophagy is a cellular degradation pathway essential for neuronal health and function. Autophagosome biogenesis occurs at synapses, is locally regulated, and increases in response to neuronal activity. The mechanisms that couple autophagosome biogenesis to synaptic activity remain unknown. In this study, we determine that trafficking of ATG-9, the only transmembrane protein in the core autophagy pathway, links the synaptic vesicle cycle with autophagy. ATG-9-positive vesicles in C. elegans are generated from the trans-Golgi network via AP-3-dependent budding and delivered to presynaptic sites. At presynaptic sites, ATG-9 undergoes exo-endocytosis in an activity-dependent manner. Mutations that disrupt endocytosis, including a lesion in synaptojanin 1 associated with Parkinson's disease, result in abnormal ATG-9 accumulation at clathrin-rich synaptic foci and defects in activity-induced presynaptic autophagy. Our findings uncover regulated key steps of ATG-9 trafficking at presynaptic sites and provide evidence that ATG-9 exo-endocytosis couples autophagosome biogenesis at presynaptic sites with the activity-dependent synaptic vesicle cycle.

Indexed as

Caenorhabditis elegansSynaptic VesiclesAnimalsAutophagyAutophagy-Related ProteinsEndocytosisPresynaptic TerminalsAutophagy-Related ProteinsAP-3ATG-9autophagyclathrinendocytosisGolgi apparatusneuronal activityParkinson’s diseasesynaptic vesicle cyclesynaptojanin 1/unc-26

Identifiers

PMID35065714
PMCPMC9017068
OpenAlexW4220988819

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.